TREATMENT REFRACTORY MAC LUNG DISEASE

Clinical trials for TREATMENT REFRACTORY MAC LUNG DISEASE explained in plain language.

Never miss a new study

Get alerted when new TREATMENT REFRACTORY MAC LUNG DISEASE trials appear

Sign up with your email to follow new studies for TREATMENT REFRACTORY MAC LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Inhaled drug trial aims to clear stubborn lung bugs

Disease control Terminated

This study tested whether adding an inhaled antibiotic called clofazimine to standard treatment could help people with a persistent lung infection caused by nontuberculous mycobacteria (NTM). The main goals were to see if the inhaled drug could clear the bacteria from the lungs a…

Matched conditions: TREATMENT REFRACTORY MAC LUNG DISEASE

Phase: PHASE3 • Sponsor: Mannkind Corporation • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

TREATMENT REFRACTORY MAC LUNG DISEASE

Get alerted when new TREATMENT REFRACTORY MAC LUNG DISEASE trials appear

Inhaled drug trial aims to clear stubborn lung bugs